Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SPIR stock price vs MPW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MPW's multiple
Needs MPW P/E.
Implied fair value · at SPIR's multiple
Needs Annual EPS is negative, SPIR P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SPIRE GLOBAL, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
MEDICAL PROPERTIES TRUST INC · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Iridium Communications Inc.
SPIR vs IRDM
Globalstar, Inc.
SPIR vs GSAT
VIASAT INC
SPIR vs VSAT
AST SpaceMobile, Inc.
SPIR vs ASTS
Sabra Health Care REIT, Inc.
SPIR vs SBRA
WELLTOWER INC.
SPIR vs WELL
Ventas, Inc.
SPIR vs VTR
NATIONAL HEALTH INVESTORS INC
SPIR vs NHI
OMEGA HEALTHCARE INVESTORS INC
SPIR vs OHI
LTC PROPERTIES INC
SPIR vs LTC
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe SPIR can reverse its -35.2% revenue decline and improve operating execution from a -134.1% operating margin, then holding or accumulating near the lower end of its valuation bands is defensible because the current $18.44 price is still inside both the historical and DCF ranges.
SPIR’s current price of $18.44 sits inside its historical band of $16.60-$20.28 and also within its DCF range of $14.39-$19.47, suggesting the stock is not obviously cheap or expensive on the data provided. Relative to MPW, SPIR has a clearly smaller and more leveraged-to-growth profile, but the comparison is distorted because MPW lacks P/E, P/S, and EV-based multiples in the dataset.
Supporting Metrics
